About Etacept 25 Mg Injection
Highlighted for its potent action and crowning efficacy, Etacept 25 Mg Injection is a blue-ribbon therapeutic solution designed to grab attention in autoimmune disease management. This ready-to-use, single-use vial contains 25mg of Etanercept in a 0.5ml sterile solution, ensuring instant checkout and convenient administration. Marketed by Cipla Limited, it inhibits TNF- and offers a neutral pH, clear to slightly opalescent texture, and is completely odorless. Indicated for adults, it is prescribed for managing rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Store between 2C-8C for maximum shelf life.
Etacept 25 Mg Injection: Commercial Uses and Benefits
Etacept 25 Mg Injection is widely used in the treatment of debilitating autoimmune diseases, delivering reliable results for patients with rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Its primary competitive advantage lies in its blue-ribbon TNF inhibitor profile, formulated for adult patients needing rapid symptom relief. Healthcare professionals use Etacept for its crowning potency, ready-to-use packaging, and neutral pH, giving it an edge in medical and clinical settings across India and global export markets.
Delivery Time, Domestic Market & Packaging Details
Expect prompt supply and quick dispatch of Etacept 25 Mg Injection across the main domestic markets of India. The estimated delivery time is minimized through efficient logistics, ensuring the product reaches customers swiftly. Each vial is securely packaged in a sterile, ready-to-use 0.5ml container, upholding industry standards for pharmaceutical exports. This streamlined approach ensures clients receive blue-ribbon quality with every order, whether for domestic hospitals or international trade partners.
FAQ's of Etacept 25 Mg Injection:
Q: How should Etacept 25 Mg Injection be stored for optimal effectiveness?
A: Etacept 25 Mg Injection should be stored at a temperature range between 2C and 8C. It must not be frozen to ensure the integrity and efficacy of the solution remain uncompromised. Always keep it in its original packaging and protect it from direct light.
Q: What conditions does Etacept 25 Mg Injection treat?
A: Etacept 25 Mg Injection is indicated for the treatment of autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis in adult patients, by inhibiting tumor necrosis factor (TNF)-.
Q: Where is Etacept 25 Mg Injection manufactured and marketed?
A: Etacept 25 Mg Injection is manufactured and marketed by Cipla Limited, a trusted pharmaceutical company headquartered in India, with distribution across domestic and international markets.
Q: What is the process for administering Etacept 25 Mg Injection?
A: This injection is administered subcutaneously and is available as a ready-to-use, single-use sterile vial. A healthcare professional should perform the injection under prescription and sterile conditions.
Q: When should Etacept 25 Mg Injection be used?
A: Etacept 25 Mg Injection should only be used when prescribed by a healthcare provider, typically in adult patients diagnosed with specific autoimmune conditions that have not responded adequately to conventional treatments.
Q: What are the main benefits of using Etacept 25 Mg Injection?
A: The injection offers a potent, neutral-pH solution with rapid symptom control, convenient single-use packaging, and a long shelf life of up to 24 months, making it an ideal option for medical practitioners and patients requiring targeted autoimmune disease management.